STRATA Skin Sciences, Inc. (SSKN)

OTCMKTS · Delayed Price · Currency is USD
0.1300
-0.0100 (-7.14%)
At close: May 28, 2026
Market Cap765.47K -92.8%
Revenue (ttm)30.70M -8.5%
Net Income-6.26M
EPS-1.35
Shares Out 5.89M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume47,164
Open0.1400
Previous Close0.1400
Day's Range0.1200 - 0.1488
52-Week Range0.1100 - 3.8600
Beta-0.05
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through Dermatology Recurring Procedures and Dermatology Procedures Equipment segments. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma; and TheraClear acne therapy sy... [Read more]

Sector Healthcare
Founded 1989
Employees 114
Stock Exchange OTCMKTS
Ticker Symbol SSKN
Full Company Profile

Financial Performance

In 2025, STRATA Skin Sciences's revenue was $30.70 million, a decrease of -8.54% compared to the previous year's $33.56 million. Losses were -$6.26 million, -37.92% less than in 2024.

Financial Statements

News

New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo

Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination therapy in children aged 2–18 years with progressive vit...

11 days ago - GlobeNewsWire

STRATA Skin Sciences Annual report: Q4 2025

STRATA Skin Sciences has published its Q4 2025 annual report on March 26, 2026.

2 months ago - Filings

Strata Skin Sciences confirms Nasdaq delisting

Strata Skin Sciences (SSKN) announces that a Form 25 has been filed today with the SEC to deregister its common stock under Section 12(b) of the Securities Exchange Act of…

3 months ago - TheFly

STRATA Skin Sciences Confirms Nasdaq Delisting

HORSHAM, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and market...

3 months ago - GlobeNewsWire

Strata Skin announces Johns Hopkins Dermatology added XTRAC 308 nm to offerings

STRATA Skin Sciences (SSKN) announces that Johns Hopkins Dermatology has added the XTRAC 308 nm excimer laser to its clinical treatment offerings. The addition of XTRAC enhances Johns Hopkins’ ability...

3 months ago - TheFly

Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser

HORSHAM, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative dermatologic ...

3 months ago - GlobeNewsWire

Strata Skin announces findings from February 2026 review of Excimer laser

Strata Skin Sciences (SSKN) highlights findings from a February 2026 systematic review and meta-analysis confirming the clinical efficacy of 308 nm Excimer laser in plaque psoriasis. Published in the ...

3 months ago - TheFly

STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis

Growing body of clinical data like February 2026 publication from Georgetown University supports optimized, targeted Excimer laser UVB strategies for inflammatory skin conditions Growing body of clini...

3 months ago - GlobeNewsWire

Laseroptek America Files Counterclaims Alleging Anticompetitive and Unfair Business Practices in Ongoing Litigation with Strata Skin Sciences

LAGUNA HILLS, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Laseroptek America Corp. (“Laseroptek America” or “LOA”) today announced that it has filed counterclaims and third-party claims against Strata S...

3 months ago - GlobeNewsWire

Strata Skin Sciences showcases XTRAC, TheraclearX at TeraCILAD 2025

STRATA Skin Sciences (SSKN) announces its participation in the 2025 Ibero-Latin American Congress of Dermatology November 19-22, 2025, where it presented its XTRAC excimer laser and TheraclearX acne t...

6 months ago - TheFly

STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico

HORSHAM, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies, announces its participation in the 2025 Ibero-Latin A...

6 months ago - GlobeNewsWire

STRATA Skin Sciences Earnings Call Transcript: Q3 2025

Q3 2025 saw strong U.S. recurring revenue and record device billings, offset by a 20% drop in total revenue due to international headwinds. Expanded CPT codes and litigation wins are set to drive future growth, with TheraClearX expanding in Mexico and the U.S.

7 months ago - Transcripts

STRATA Skin Sciences Quarterly report: Q3 2025

STRATA Skin Sciences has published its Q3 2025 quarterly earnings report on November 13, 2025.

7 months ago - Filings

STRATA Skin Sciences Earnings release: Q3 2025

STRATA Skin Sciences released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.

7 months ago - Filings

Strata Skin Sciences announces CMS recognition of expanded CPT codes

STRATA Skin Sciences (SSKN) announced that the Centers for Medicare & Medicaid Services, CMS, has issued its CY 2026 Medicare Physician Fee Schedule Final Rule confirming continued reimbursement for e...

7 months ago - TheFly

STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion

Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion Higher reimbursement, regulatory ...

7 months ago - GlobeNewsWire

STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update

HORSHAM, Penn., Nov. 05, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and mark...

7 months ago - GlobeNewsWire

STRATA Skin Sciences Proxy statement: Proxy Filing

STRATA Skin Sciences filed a proxy statement on October 30, 2025, providing details for shareholder voting and corporate governance matters.

7 months ago - Filings

Strata Skin Sciences announces COFEPRIS clearance of TheraClear in Mexico

STRATA Skin Sciences (SSKN) announced that its TheraClearX acne treatment system has received regulatory clearance from the Mexican health authority, COFEPRIS, under Device Registration No. 3187E2024S...

7 months ago - TheFly

Strata Skin Sciences provides update on positioning, litigation

STRATA Skin Sciences (SSKN) provided an update on its competitive positioning and ongoing litigation against LaserOptek America Corp., LaserOptek, and affiliated entities including The Pinnacle Health...

7 months ago - TheFly

STRATA Skin Sciences Proxy statement: Proxy Filing

STRATA Skin Sciences filed a proxy statement on October 20, 2025, providing details for shareholder voting and corporate governance matters.

7 months ago - Filings

Why Is Strata Skin Sciences Stock (SSKN) Up Today?

Strata Skin Sciences stock rallied alongside positive clinical data related to its excimer laser.

8 months ago - TipRanks

Strata Skin Sciences announces clinical case study on 308-nm excimer laser

STRATA Skin Sciences (SSKN) announces a clinical case study published in Case Reports in Oncology. The study reports the successful use of 308-nm excimer laser to treat a rare and…

8 months ago - TheFly

Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides

First English-language case study shows resolution of lesions with 308-nm Excimer laser in rare mycosis fungoides (MF) subtype, poikilodermatous mycosis fungiodes (pMF), underscoring the Company's XTR...

8 months ago - GlobeNewsWire

Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis

HORSHAM, Pa., Oct. 03, 2025 (GLOBE NEWSWIRE) -- In recognition of Eczema Awareness Month, STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated ...

8 months ago - GlobeNewsWire